AwardedSpainGoods€391,541
Suministro de Medicamento Ublituximab 150 mg vial (BRIUMVI) de distribución exclusiva del Laboratorio Neuraxpharm Spain S.L con destino al Servicio de Farmacia del Hospital Clínico San Carlos
- Published
- Published 12 May 2026
Overview
Hospital Clínico San Carlos procured Ublituximab 150 mg vials (BRIUMVI), an exclusive distribution pharmaceutical product from Laboratorio Neuraxpharm Spain S.L for its Pharmacy Service. The contract was awarded to Laboratorio Neuraxpharm Spain S.L on 7 May 2026 for €177,972.96.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €391,541
- Procedure
- Direct
- Published
- 12 May 2026
Pharmaceutical products
Award outcome
- Awarded value
- €177,973
- Award date
- 7 May 2026
- Contract period
- — → 26 April 2028
- LABORATORIO NEURAXPHARM SPAIN S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 May 2026
Contracting authority
HOSPITAL CLINICO SAN CARLOS
Procuring entityMadrid, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.